The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world study of patients with metastatic castration-resistant prostate cancer (mCRPC) treated with enzalutamide (ENZA) or abiraterone acetate plus prednisone (AA+P): Patient characteristics and treatment persistence.
 
Kelvin A. Moses
No Relationships to Disclose
 
David F. Penson
Consulting or Advisory Role - Astellas Pharma; Dendreon
Research Funding - Astellas Pharma (Inst); Medivation (Inst)
 
Neil M. Schultz
Employment - Astellas Pharma
Stock and Other Ownership Interests - Gilead Sciences; Shire
 
Fei Shi
Employment - Astellas Pharma
 
Samuel Wilson
Employment - Astellas Pharma
Stock and Other Ownership Interests - Baxter (I)
Research Funding - Astellas Pharma
 
Bruce A. Brown
Employment - Astellas Pharma
 
Arie Barlev
Employment - Medivation
Stock and Other Ownership Interests - Medivation
 
Scott Flanders
Employment - Astellas Pharma
Stock and Other Ownership Interests - Johnson & Johnson
Travel, Accommodations, Expenses - Astellas Pharma